If the new legislation comes through for diagnostics, that'd add an extra 1-2b on top of valuations for cu6 in terms of acquisition price. Knowing your product doesn't fall off a revenue cliff in 3 years is massive.
Research/Valuation, page-545
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.06 |
Change
-0.400(5.36%) |
Mkt cap ! $2.260B | |||
| Open | High | Low | Value | Volume |
| $7.46 | $7.68 | $7.00 | $6.919M | 955.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3249 | $7.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.09 | 816 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |